Trial Profile
Cisplatin With Either Alimta or Gemcitabine in Long Infusion for Mesothelioma: A Randomised Phase II Trial (AGILI Trial)
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary) ; Pemetrexed (Primary) ; Cisplatin
- Indications Mesothelioma
- Focus Therapeutic Use
- Acronyms AGILI
- 04 Feb 2011 New trial record